Aggrastat lowers death risk after unstable angina study shows
Two trials show Aggrastat tirofiban added to aspirin or heparin reduces death after unstable angina or mild heart attack. In New Zealand, 3,232 patients receiving Aggrastat had 2.3 percent deaths versus 3.6 percent on heparin at one month. In Canada, results varied by severity with mixed outcomes across groups and a 44 percent reduction in heart attacks when Aggrastat plus heparin was used.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
Harvey White
Green Lane Hospital
Auckland
New Zealand
Pierre Theroux
Montreal Heart Institute
Canada
Associated Press
New England Journal of Medicine
Merck & Co
James Chesebro
Juan Badiman
Mount Sinai Medical Center
Also Mentioned on This Page
Mr. Payroll
Peery Ra
Creeleed
Cos
Erry
Oly
Namanga
Allen Young Homes II
Crestline Mobile & Modular Homes
CSRA
Palm Harbor
Riverchase
Bellcrest
Silhouette
A & SC
Richland Avenue
Aiken
Assic Interior
Silver Bluff RD
Voo
Sherwin-Williams
North Augusta
Martintown